Foundation Medicine, Inc., a global precision medicine company, today announced an expansion to its collaboration with Bristol Myers Squibb (NYSE: BMY) to develop FoundationOne®CDx as a ...
Medical experts illustrate an array of characteristics presented in patients with HoFH. Erin Michos, MD, MHS: In homozygous FH [familial hypercholesterolemia], the LDL [low-density lipoprotein] ...
Eliot Brinton, MD, opens a discussion surrounding the treatment landscape for patients with homozygous familial hypercholesterolemia (HoFH). Eliot Brinton, MD: I’m Dr Elliot Brinton. I’m the president ...
For years, father of two Peter Martini experienced subtle symptoms that never seemed serious enough to raise alarm, but in ...
The FDA said today that it had granted approval to the novel cholesterol-lowering drug mipomersen sodium for use as an adjunct to diet and drug therapy in patients with homozygous hypercholesterolemia ...
Homozygous familial hypercholesterolemia is characterized by profound genetic deficiencies in the low-density lipoprotein (LDL) receptor pathway; patients with the condition who are not receiving ...
Familial hypercholesterolemia (FH) is characterized by the accumulation of excess cholesterol in tissues including the artery wall and tendons. We describe a patient with homozygous FH who presented ...
Around the world, patients with homozygous familial hypercholesterolemia (HoFH) are diagnosed too late in life and remain significantly undertreated with LDL cholesterol-lowering medications, ...
Prolonged survival in homozygous sickle cell disease is more common than previously thought. A Jamaican study 1 in 1968 described 60 patients who were 30 years of age or older, and the Cooperative ...
Hemochromatosis is a condition in which too much iron builds up in the body. When people inherit the condition via their genes, it can be heterozygous or homozygous. “Heterozygous” means the person ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results